相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
S. Petta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study
Tania M. Welzel et al.
GUT (2017)
The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection
J. Vermehren et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection
Mark S. Sulkowski et al.
GASTROENTEROLOGY (2016)
Safety and Efficacy of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Hepatitis C in Subjects Aged 65 Years or Older
Sammy Saab et al.
HEPATOLOGY (2016)
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Fabio Conti et al.
JOURNAL OF HEPATOLOGY (2016)
Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment
Karin Kozbial et al.
JOURNAL OF HEPATOLOGY (2016)
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2016)
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population
Savino Bruno et al.
JOURNAL OF HEPATOLOGY (2016)
Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free Regimens
Zobair M. Younossi et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2016)
Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus
Mehdi Najafzadeh et al.
ANNALS OF INTERNAL MEDICINE (2015)
Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States
Jagpreet Chhatwal et al.
ANNALS OF INTERNAL MEDICINE (2015)
Hepatitis C Infection in the Elderly
Sammy Saab et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection
Graham R. Foster et al.
GASTROENTEROLOGY (2015)
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis
Bashar A. Aqel et al.
HEPATOLOGY (2015)
Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis
Varun Saxena et al.
HEPATOLOGY (2015)
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study
Christophe Hezode et al.
GUT (2015)
Concordance of Sustained Virological Response 4, 12, and 24 Weeks Post-Treatment With Sofosbuvir-Containing Regimens for Hepatitis C Virus
Eric M. Yoshida et al.
HEPATOLOGY (2015)
Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2014)
Retreatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Treatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin
Jordan J. Feld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
ABT-450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV
Peter Ferenci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection
Claudia Roeder et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Health-related quality of life in genotype 1 treatment-naive chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study
M. Vera-Llonch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Hepatitis C Virus Testing of Persons Born During 1945-1965: Recommendations From the Centers for Disease Control and Prevention
Bryce D. Smith et al.
ANNALS OF INTERNAL MEDICINE (2012)
Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver
Annagiulia Gramenzi et al.
DIGESTIVE AND LIVER DISEASE (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
Gary L. Davis et al.
GASTROENTEROLOGY (2010)
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study
A. Gramenzi et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Efficacy of peginterferon-α-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C
Takashi Honda et al.
LIVER INTERNATIONAL (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Age and Prediction of Sustained Virological Response to Hepatitis C Virus (HCV) Infection Treatment Based on 28-Day Decrease in HCV RNA Levels
Giorgio Antonucci et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis
Herbert L. Bonkovsky et al.
JOURNAL OF HEPATOLOGY (2007)
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study
Savino Bruno et al.
HEPATOLOGY (2007)
Hepatitis C in 6,865 patients 65 yr or older: A severe and neglected curable disease?
Dominique Thabut et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C
Y Iwasaki et al.
HEPATOLOGY (2006)
Prevalence of antibodies against hepatitis C virus in the elderly: A seroepidemiological study in a nursing home and in an open population
V Baldo et al.
GERONTOLOGY (2000)
分享论文
